BTIG lowered the firm’s price target on Mereo BioPharma (MREO) to $1 from $6 and keeps a Buy rating on the shares after the company announced th...
Mereo BioPharma price target lowered to $1 from $6 at BTIG
BTIG lowered the firm’s price target on Mereo BioPharma (MREO) to $1 from $6 and keeps a Buy rating on the shares after the company announced th...
